Caffeine acts by antagonizing the effect of the endogenous homeostatic sleep factor adenosine. In the current study we aimed to evaluate the pattern of caffeine-induced insomnia and its relation to age and sex in a general population sample derived from a web survey. The sample included 75,534 participants (28.1% men) from 18 to 75 years who answered self-report questionnaires by accessing a website in Brazilian Portuguese (BRAINSTEP project). In our sample, 3620 (17.0%) men and 9920 (18.3%) women reported insomnia due to caffeine intake. Caffeine-induced insomnia increased with aging in both men and women. This difference remained after adjusting for sociodemographic, psychiatric and sleep related variables as well as caffeine intake. Women showed higher proportion of caffeine-induced insomnia than men, but this difference did not remain after controlling for covariates. Also, individuals with caffeine-induced insomnia reported poorer sleep quality, higher latency to fall asleep and a higher proportion of psychiatric diagnoses and daily use of hypnotic drugs. In conclusion, our results show an age-associated increase in caffeine-induced insomnia and poorer mental health indicators among people with caffeine-induced insomnia complaints.
Introduction
Caffeine is a methylxanthine widely used due to its psychoactive effects (Hindmarch et al., 2000) . The dietary source of caffeine is predominantly coffee, but it is also present in tea, chocolate, energy drinks, cola drinks and some medications (Barone and Roberts, 1996) . Upon acute consumption, its central effects include increased alertness, motivation, energy, concentration and vigilance performance on psychomotor tasks, even at low (e.g. 30 mg) doses (Cunha et al., 2008; Hindmarch et al., 2000; Lieberman et al., 1987) ; in contrast, higher doses can produce anxiety (Smit and Rogers, 2000) . Most people seem to self-regulate their use to maximize the beneficial effects and avoid adverse effects, which explains the absence of negative effects upon moderate caffeine intake (Smith, 2002) . In fact, the regular consumption of moderate doses of caffeine is associated with better health prognosis (Freedman et al., 2012; O'Keefe et al., 2013) , some regulation of mood (Lucas et al., 1990 ) and better memory (Santos et al., 2010) throughout life.
It is well documented that caffeine affects sleep (Clark and Landolt, 2017; Porkka-Heiskanen, 2011) . At non-toxic doses, the effect of caffeine primarily results from the antagonism of adenosine A 1 and A 2A receptors (Fredholm et al., 1999) . Animal studies show that these adenosine receptors are critically involved in sleep regulation and energy homeostasis (Huang et al., 2014) , which is in notable agreement with the association of A 2A receptor polymorphisms with different sleeping patterns (Byrne et al., 2012; Rétey et al., 2007) and with caffeine-induced alertness in humans (Bodenmann et al., 2012; Rogers et al., 2010) . The most commonly reported effect of acute or short-term controlled caffeine consumption is prolonging sleep latency, which decreases total sleep time and may impair sleep quality (Clark and Landolt, 2017) . Nevertheless, epidemiological studies show that individuals perceive little sleep disturbance related to life-long coffee and/or caffeine consumption (Goldstein and Kaizer, 1969; Hicks et al., 1983; Mniszek, 1988) .
One factor that is likely to influence the impact of coffee and/ or caffeine intake on sleep is aging, which affects adenosine formation , the activation of adenosine receptors (Cunha et al., 1995) , the consumption of caffeine (Barone and Roberts, 1996; Knight et al., 2004) and the pattern of sleep (Mattis and Sehgal, 2016) . A decreased consumption of coffee with age has been associated with poorer subjective sleep quality (Curless et al., 1993; Soroko et al., 1996) and laboratory studies showed that higher doses of caffeine (400 mg) cause greater increase of sleep latency and shortening of total sleep duration in middle-aged than in young adults (Robillard et al., 2015) .
Another relevant factor related to caffeine consumption is gender. In attention tasks, males have shorter reaction times with high doses of caffeine (300 mg), but not with moderate doses (150 mg), compared with women, despite no gender difference in the pharmacokinetics of caffeine (Botella et al., 2001) . Also, Suvi et al. (2013) reported a reduction in ratings of perceived exertion and fatigue in males but not in females under exercise-heat stress with coffee consumption (Suvi et al., 2013 ).
In the current study, we aimed to evaluate the impact of age on the pattern of insomnia induced by caffeine in a large sample of the general population. We hypothesized that older individuals would be more sensitive to caffeine, due to age-related modification in adenosine receptors, resulting in worse sleep indicators related to the presence of insomnia, poorer quality of sleep and longer latencies required for sleep consolidation. Also, we aimed to evaluate the possibility of different patterns of caffeine sensitivity between males and females and its relation to covariates.
Methods

Procedures
This study was part of a large web-based survey to study temperament, psychiatric disorders and psychobiological measures named Brazilian Internet Study on Temperament and Psychopathology (BRAINSTEP) (Lara et al., 2012) . Participants answered the questionnaire by accessing a website in Brazilian Portuguese (www.temperamento.com.br). This Internet-based research was broadcast on national TV news programs in Brazil and featured in local newspapers. Subjects received a feedback on their temperament profile after responding to about half of the ~900 questions, and on the chance of having a psychiatric disorder after the second half. The profile of the sample is biased towards young adults, women and higher socioeconomic status, but the rate of the main psychiatric disorders is similar to their prevalence reported in classical epidemiological studies (Lara et al., 2012) . Such methodology has the advantage that all items are necessarily answered, no mistakes of data transfer are expected to occur and identification is only partial (through e-mail address; names were not required). To ensure reliability of the data, questions checking for attention and inconsistent responding (validity checks) were present within the questionnaire.
All participants gave their electronic informed consent before completing the questionnaire. Their participation was voluntary and they could cancel their participation at any moment without justification. The study protocol fulfilled the requirements of the National Health Council of Brazil (Resolution 196/1996) 
Participants
Individuals aged from 18 to 75 years with correct answers in the validity checks (80.5% of the initial sample) were included in the analysis. The final sample consisted of 75,534 subjects, with 28.1% (21,240) men and 71.9% (54,294) women. The mean age of the sample was 30.25 ± 10.29 years for men and 30.27 ± 10.03 years for women. Due to the predominance of participants younger than 50 years (median = 27 years of age) and to balance the discrepancy of proportion between younger and older participants, the sample was clustered in age groups organized in three year groupings (e.g. 18-20, 21-23, 24-26… years old). Each age group contained at least 900 subjects, which guaranteed statistical power and comparability among age groups (Figure 1 ). A total of 71,996 subjects (95.3%) had at least a high school degree and 20,444 (27.1%) had received a psychiatric diagnosis from a mental health professional.
Measures
Participants answered questions about their caffeine intake pattern and insomnia. In regard to caffeine consumption and on the standard measure of coffee in Brazil (50 mL), participants were classified into five categories according to the number of cups of coffee consumed daily: very low (<50 mL/day of brewed or instant coffee as used in Brazil or less than 25 mg caffeine/day), low (50-100 mL or around 50 mg/day), moderate (>100-300 mL/day or around 100 mg/day), high (>300-500 mL/day or around 200 mg/day) and very high (>500 mL/day or >250 mg/ day). Cola drink intake was divided into six categories: nonusers, very low <1 L/week), low (1-2 L/week), moderate (2-4 L/week), high (5-10 L/week) and very high (>10 L/week). Tea intake was divided into five categories: non-users, low (<500 mL/week), moderate (500 mL-2 L/week), high (2-5 L/week) and very high (>5 L/week). Insomnia associated with caffeinated drinks was assessed by self-report to the question 'Do you have insomnia by consuming coffee or caffeinated beverages (black tea, mate) at night?' followed by a yes/no option. We also divided the sample according to current use of sleep inducers into three categories: non-users, occasional users and daily users. Sleep quality was evaluated in a Likert scale ranging from very unsatisfied to very satisfied (scores 1-6), and sleep latency was evaluated asking about time taken to fall asleep with answers ranging from 5 min to 60 min or more, but this measure was categorized as ⩽ 30 min or > 30 min. Both questions are adapted from the Oviedo sleep questionnaire (Bobes et al., 2000; Paz García-Portilla et al., 2009 ).
Statistical analysis
Univariate analyses were used to describe sample characteristics. Bivariate analyses (chi-square test, Mann-Whitney and t-tests) were used to compare people with and without caffeine-induced insomnia in regard to gender, age, coffee consumption, psychiatric diagnoses, use of psychotropic drugs and hypnotics, sleep quality and latency. Associations were considered to be significant at p value ⩽ 0.05. Adjusted analysis (logistic regression) was then used to calculate the odds ratios (ORs) for the chance of having caffeine-induced insomnia (dependent variable) considering the variables previously analyzed. Age was ordered in groups of three years (18-20, 21-23, 24-26…) , considering the group of 18-20 years old as reference. This reference group was chosen for three main reasons: (1) sample size was one of the highest; (2) they are the first age group, which simplifies the visual comprehension of the results, and (3) as the youngest group it is plausible to assume that they would show fewer health issues that may interfere with sleep. Regression analysis was performed at three levels: at level 1, age and gender were used to predict caffeineinduced insomnia with no adjustment for other covariates; at level 2, coffee, cola drinks and tea intake were included along with psychiatric diagnosis, use of psychotropic drugs and cigarette smoking; level 3, time to fall asleep, sleep quality, and use of sleeping pills were included.
Results
Our initial findings showed gender differences in the prevalence of insomnia due to caffeine intake and an increase in the proportion of individuals with caffeine-induced insomnia with age (Figure 2(a) ).
In our sample, 13,540 (17.9%) participants reported insomnia due to caffeine intake, of which 3620 (17.0%) were men and 9920 (18.3%) were women and this proportion difference was statistically significant (χ 2 = 15.638, df = 1, p < 0.001). As shown in Table 1 , men and women who reported caffeine-induced insomnia had a higher coffee consumption. Also, individuals with caffeine-induced insomnia reported more frequently a poorer sleep quality and sleep latency >30 min. In both genders, caffeine-induced insomnia was associated with a positive history of psychiatric diagnoses and with current use of psychiatric drugs and hypnotics, but not with current smoking.
Women tended to show a steady increase in caffeine-induced insomnia with age, while men reached a plateau after 33 years old. However, these differences between women and men were significant only for the following age groups: 27-29, 36-38, 39-41, 42-44, 45-47, 48-50, 54-56, and 60 and over. These distinct gender patterns occurred despite the similar age-associated rise in coffee consumption in both genders up to 51-54 years and a slight decrease afterwards (Figure 2(b) ). Men drink more coffee than women in all age groups (p ⩽ 0.001).
The assessed sleep patterns (poor quality of sleep and latency to consolidate sleep) also showed different profiles for men and women. Women increasingly reported a poor quality of sleep until 36 years, which then reached a plateau, followed by a decrease of complaints of poor sleep after 51 years. By contrast, the percentage of men reporting a poor quality of sleep remained stable until 42 years, decreasing afterwards (Figure 2(c) ). Inferential analysis showed that men tend to report more complaints than women between 18 and 23 years, while women tend to show a worse sleep pattern between 33 and 35 and when older than 60 years.
The percentage of women who took longer to fall asleep (>30 min) remained relatively stable across all ages, whereas in men it was stable until 36 years, declining afterwards. Gender differences were significant for all ages, showing that women tended to take longer than men to consolidate sleep (Figure 2(d) ).
As shown in Figure 3 , the OR for caffeine-induced insomnia related to age displayed a positive association, showing some decrease among participants of 57 years or older. The effect of gender on caffeine-induced insomnia was less robust: at the first level of multivariate analysis, when no adjustments for covariates were performed, women showed small but significantly higher rates of caffeine-induced insomnia (OR = 1.12) when compared with men; in the second and third level of analysis -when variables related to caffeine intake, clinical and sleep variables were included -gender did not show any association with caffeineinduced insomnia.
Among covariates, in the regression model level 3, coffee intake was associated with caffeine-induced insomnia at all caffeine intake groups: low, OR = 1.12; moderate, 1.36; high, OR = 1.71; very high, OR = 1.93. Tea intake was not associated; however, cola drinks displayed significant associations with caffeine-induced insomnia ranging from OR = 1.27 for low intake, to 1.89 to very high. Occasional use of psychiatric medication (OR = 1.13), use of hypnotics (OR ≅ 1.65) and having received a mental disorder diagnosis (OR = 1.36) were also positively associated with the presence of caffeineinduced insomnia. 
Discussion
In this study, we found a positive association between caffeineinduced insomnia and age for both men and women, even when controlling for covariates related to caffeine intake, mental health and sleep. This finding is in agreement with the reported higher consumption of tea (which may also contain methylxanthines) in aged individuals reporting insomnia (Morgan et al., 1989) , the higher levels of caffeine in hospitalized elderly patients with insomnia complaints (Curless et al., 1993) and with the decrease in coffee and caffeine intake with age attributed to their increased negative impact of sleep quality (Soroko et al., 1996) . Controlled studies have also shown that middle-aged individuals tend to be more sensitive to a higher dose of caffeine (400 mg; but not 200 mg) when compared with young adults, even when no differences in metabolism are encountered as observed by their similar salivary caffeine concentrations (Robillard et al., 2015) . The biological basis for this age-related impact of caffeine intake on sleep may be associated with the alterations in the aging brain of the main targets of caffeine, that is, adenosine receptors (Fredholm et al., 1999) . Studies in animals have identified that adenosine A 2A receptors play a predominant role in sleep induction (Huang et al., 2014; Satoh et al., 1999) and on the impact of caffeine on sleep (Huang et al., 2005) , which is reinforced by the association of A 2A receptor polymorphisms with alterations of the pattern of sleep (Byrne et al., 2012; Rétey et al., 2007) . Aging decreases the density of A 2A receptors in limbic regions, but not in the basal ganglia (Cunha et al., 1995) . Therefore, there might be an age-related alteration of the role of A 2A receptors in the control of cortical acetylcholine (Rodrigues et al., 2008 ) that controls behavioral arousal in the prefrontal cortex (Van Dort et al., 2009) , whereas there might be a preservation of A 2A receptor function in other areas associated with caffeineinduced wakefulness, such as the pontine reticular formation (Coleman et al., 2006) , the ventrolateral preoptic area (Scammell et al., 2001) or the shell region of the nucleus accumbens (Lazarus et al., 2011) . By contrast, inhibitory A 1 receptors, which regulate the sleep-wake cycle in a site-dependent manner (Huang et al., 2014) , undergo a steady decrease of their density ) and efficiency (Sebastião et al., 2000) in the brain. Thus, there might be an age-related decrease of the A 1 receptor-mediated inhibition of the wake-promoting neurons in the cholinergic basal forebrain (Bjorness et al., 2009) as well as in prefrontocortical neurons controlling the release of acetylcholine in the pontine reticular formation (Van Dort et al., 2009 ) that are critically involved in the sleep-inducing effects of adenosine (Huang et al., 2014) . This suggests an increased vulnerability of the circadian waking signal to caffeine in middle-aged compared with young subjects (Robillard et al., 2015) and provides a biological rationale for our observation of an increased incidence of caffeineinduced insomnia with aging.
This observed greater deleterious effect of caffeine intake with aging on sleep quality is interesting in view of the general increased consumption of caffeinated beverages upon aging (Barone and Roberts, 1996; Knight et al., 2004) and the increased awareness that a decreased sleep quality is a critical susceptibility factor for the emergence or evolution of neuropsychiatric disorders (Mattis and Sehgal, 2016) . Since the consumption of caffeine is normally self-regulated, the age-associated increase of caffeine consumption (Barone and Roberts, 1996; Knight et al., 2004) may be related to even greater compensatory beneficial effects of regular caffeine consumption on the normalization of mood (Lucas et al., 2011) and cognitive function (Santos et al., 2010) , in spite of its deleterious effects on the pattern of sleep. Compared with men, women showed a higher chance of reporting caffeine-induced insomnia when controlling for age and gender. However, this difference failed to remain when variables related to caffeine intake, psychiatric diagnosis, use of psychiatric drugs and sleep covariates were included in the regression model. Despite these findings, other effects of caffeine in the brains of men and women are somewhat different: there are substantial differences between men and women in the neuroprotective effects of caffeine on age-related cognitive decline (Johnson-Kozlow et al., 2002; Ritchie et al., 2007) or the incidence of Parkinson's disease (Ascherio et al., 2001) . Epidemiological and animal studies have converged to suggest that the interaction of estrogens with adenosine A 2A receptors may underlie these gender differences to the susceptibility to caffeine (Ascherio et al., 2004; Xu et al., 2006) . Estrogens affect sleep quality (Eichling and Sahni, 2005) and, remarkably, they can modify A 2A receptor mRNA expression in preoptic areas (Ribeiro et al., 2009 ). These gender differences for only some effects of caffeine prompt the need for future studies.
The main limitation of our study was the sole use of selfreports collected by means of the Internet. The survey was broadcast to the general population, but it yielded female predominance and a higher education and younger population compared with the general population. Although these sampling biases are problematic for inference on absolute prevalence of certain behaviors (e.g. insomnia), they may be less detrimental for studying associations (e.g. caffeine-induced insomnia and age), as the sample number was substantial at all ages. Therefore, this is an associative study, with no nomothetic and cause-effect ambition. Also, it is possible that caffeine consumption in different generations is a reflection of cultural changes over time, which cannot be assessed through a cross-sectional study. These biases may be dwarfed by the ease access of caffeine intake in the general population, by the age stratification of the analyses, and the report of a simple behavioral response (subjective perception of caffeine-induced insomnia).
In conclusion, the main finding of the current study provides evidence for an age-associated increase in caffeine-induced insomnia, even when controlling for various insomnia-related variables. Further studies should address the mechanisms underlying this phenomenon.
